Modified T cells demonstrated cytotoxicity against leukemia cells from HA-1+ donors with acute myeloid leukemia, acute T-cell, and B-cell lymphoblastic leukemia. This evidence concerns the gene ARHGAP45 and acute myeloid leukemia.